Meeting
2017 ASCO Annual Meeting
Ten-year overall and prostate cancer (PCa)-specific mortality in high-risk patients after high-dose-rate brachytherapy combined with external beam radiation therapy (HDR-BT/EBRT) compared with EBRT alone.
Authors
Trude Baastad Wedde
Oslo University Hospital, Oslo, Norway
Trude Baastad Wedde , Sophie Fosså , Sigmund Brabrand , Stein Kaasa , Kjell Magne Russnes , Taran Poulsen Hellebust , Gunnar Tafjord , Wolfgang Lilleby
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5059)
DOI
10.1200/JCO.2017.35.15_suppl.5059
Abstract #
5059
Poster Bd #
133
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
The effect of the timing of biochemical failure after external beam radiotherapy or low-dose-rate brachytherapy for definitive prostate cancer treatment.
First Author: Jay P. Ciezki
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term outcomes for patients with radiorecurrent prostate cancer treated with salvage combination IMRT and brachytherapy.
First Author: Michael J. Dattoli
Poster
2020 Genitourinary Cancers Symposium
The risk of death from prostate cancer in men with Gleason Score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.
First Author: David Dewei Yang
Poster
2018 Genitourinary Cancers Symposium
Clinical outcomes following biochemical recurrence among patients with Gleason score 9-10 prostate adenocarcinoma.
First Author: Kiri A Sandler